Developing a clinical trial governance framework for pharmaceutical industry-funded clinical trials

References

• Asgari, D. H., E. Khorasani, M. H. Yarmohammadian, and M. S. Ahmadzade. 2017. Evaluating the application of failure mode and effects analysis technique in hospital wards: A systematic review. Journal of Injury & Violence Research 9(1). doi:10.5249/jivr.v9i1.79. PubMed Central PMCID: PMC5279992.
   Google Scholar
• Bero, L. 2017. Addressing bias and conflict of interest among biomedical researchers. Journal of the American Medical Association 317 (17):1723–24. doi:10.1001/jama.2017.3854.
   Web of Science ®Google Scholar
• Camilleri, M., and W. J. Tremaine. 2012. Governance of clinical research. The American Journal of Gastroenterology 107 (3):336–38. doi:10.1038/ajg.2011.451.
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.gov https://clinicaltrials.gov (accessed March 12, 2018).
   Google Scholar
• Dadhich, J. P. 2012. Tackling conflict of interest and misconduct in biomedical research. Indian Pediatrics 49 (7):527–31. doi:10.1007/s13312-012-0114-5. PMID: 22885435.
   PubMed Web of Science ®Google Scholar
• Donaldson, M. S., and A. M. Capron. 1991. Institute of Medicine (US) committee on potential conflicts of interest in patient outcomes research teams. In Patient outcomes research teams: managing conflict of interest, ed. M. S. Donaldson and A. M. Capron, 61-68. Washington, DC: National Academies Press (US). 1991. Sources of Concern About Conflicts of Interest in PORTs.
   Google Scholar
• Eriotis, N., F. Stamatiadis, and D. Vasiliou. 2011. Assessing accrlitual accounting reform in greek public hospitals: An empirical investigation. International Journal of Economic Sciences and Applied Research 4 (1):153–84.
   Google Scholar
• Ghooi, R. B. 2015. Conflict of interest in clinical research. Perspectives in Clinical Research 6 (1):10–14. doi:10.4103/2229-3485.148794.
   PubMedGoogle Scholar
• Grundy, Q., R. Habibi, A. Shnier, C. Mayes, and W. Lipworth. 2018. Decoding disclosure:Comparing conflict of interest policy among the United States, France, and Australia. Health Policy 122 (5):509–18. doi:10.1016/j.healthpol.2018.03.015.
   PubMed Web of Science ®Google Scholar
• Ibrahim, K., E. A. Eada, and N. Younis. 2006. Guidance for conducting clinical trials based on drugs/medical products and Good. Clinical Practice. Guidelines: Ministry of Health-Drug control UAE 6:11–17.
   Google Scholar
• Institute of medicine. 2015 Committee on Strategies for Responsible Sharing of Clinical Trial Data; Board on Health Sciences Policy; Institute of Medicine. Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk. Washington (DC): National Academies Press (US); 2015 Apr 20. 3, The Roles and Responsibilities of Stakeholders in the Sharing of Clinical Trial Data. https://www.ncbi.nlm.nih.gov/books/NBK286000
   Google Scholar
• Kassirer, J. P., and M. Angell. 1993. Financial conflicts of interest in biomedical research. The New England Journal of Medicine 329 (8):570–71. doi:10.1056/NEJM199308193290810.
   PubMed Web of Science ®Google Scholar
• Kong, H., and P. K. Chow. 2013. Conflict of interest in research–The clinician scientist’s perspective. Annals of the Academy of Medicine, Singapore 42 (11):623–28. PMID: 24356664.
   PubMed Web of Science ®Google Scholar
• Lo, B., and M. J. Field 2009. Principles for Identifying and Assessing Conflicts of Interest in Conflict of Interest in Medical Research, Education, and Practice. Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: National Academies Press (US). https://www.ncbi.nlm.nih.gov/books/NBK22937.
   Google Scholar
• Lo, B., L. E. Wolf, and A. Berkeley. 2000. Conflict-of-interest policies for investigators in clinical trials. The New England Journal of Medicine 343 (22):1616–20. PubMed PMID:11096170.
   PubMed Web of Science ®Google Scholar
• Lundh, A., J. Lexchin, B. Mintzes, J. B. Schroll, and L. Bero. 2017. Industry sponsorship and research outcome. The Cochrane Database of Systematic Reviews 2: MR000033. doi:10.1002/14651858.MR000033.pub3.
   PubMed Web of Science ®Google Scholar
• Lundh, A., J. Lexchin, B. Mintzes, J. B. Schroll, and L. Bero. 2018. Industry sponsorship and research outcome: Systematic review with meta-analysis. Intensive Care Medicine. doi:10.1007/s00134-018-5293-7.
   PubMed Web of Science ®Google Scholar
• Morgan, S., P. Grootendorst, J. Lexchin, C. Cunningham, and D. Greyson. 2011. The cost of drug development: A systematic review. Health Policy 100 (1):4–17. doi:10.1016/j.healthpol.2010.12.002.
   PubMed Web of Science ®Google Scholar
• Morin, K., H. Rakatansky, F. A. Riddick Jr., L. J. Morse, J. M. 3. O’Bannon, M. S. Goldrich, P. Ray, M. Weiss, R. M. Sade, and M. A. Spillman. 2002. Managing conflicts of interest in the conduct of clinical trials. Journal of the American Medical Association 287 (1):78–84. doi:10.1001/jama.287.1.78. PubMed PMID: 11754712.
   Web of Science ®Google Scholar
• Nair, S. C., F. Almarzooqi, and A. Alkhamiri. 2017. Health research, regulations and ethics in the United Arab Emirates. In Research ethics in the Arab Region, ed.H. Silverman, 285–93. New York: Springer International Publishing. doi:10.1007/978-3-319-65266-5.
   Google Scholar
• Nair, S. C., and H. Ibrahim. 2015a. GCP compliance and readability of informed consent forms from an emerging hub for clinical trials. Perspectives in Clinical Research 6 (2):104–08. doi:10.4103/2229-3485.154012.
   PubMedGoogle Scholar
• Nair, S. C., and H. Ibrahim. 2015b. Assessing subject privacy and data confidentiality in an emerging region for clinical trials: United Arab Emirates. Accountability in Research 22 (4):205–21. doi:10.1080/08989621.2014.942452.
   PubMed Web of Science ®Google Scholar
• Nair, S. C., H. Ibrahim, and O. S. Askar. 2016a. Comparison of good clinical practice compliance and readability ease of the informed consents between observational and interventional clinical studies in the Emirates. Perspectives in Clinical Research 7 (3):123–27. doi:10.4103/2229-3485.184815.
   PubMedGoogle Scholar
• Nair, S. C., H. Ibrahim, and D. D. Celentano. 2013. Clinical trials in the Middle East and North Africa (MENA) Region: Grandstanding or grandeur? Contemporary Clinical Trials Communications 36 (2):704–10. doi:10.1016/j.cct.2013.05.009.
   Google Scholar
• Nair, S. C., K. P. Satish, J. Sreedharan, and H. Ibrahim. 2016b. Assessing health literacy in the eastern and middle-eastern cultures. BMC Public Health 16:831. doi:10.1186/s12889-016-3488-9.
   PubMed Web of Science ®Google Scholar
• Poustie, S. J., D. M. Taylor, A. B. Forbes, M. A. Skiba, M. R. Nelson, and J. J. McNeil. 2006. Implementing a research governance framework for clinical and public health research. The Medical Journal of Australia 185:623–26. PMID: 17181507.
   PubMed Web of Science ®Google Scholar
• Raghav, P. R., D. Kumar, and P. Bhardwaj. 2016. Experience of Delphi technique in the process of establishing consensus on core competencies. International Journal of Applied and Basic Medical Research 6 (3):191–94. doi:10.4103/2229-516X.186966.
   PubMedGoogle Scholar
• Rajabi, A., and A. Dabiri. 2012. Applying Activity Based Costing (ABC) method to calculate cost price in hospital and remedy services. Iranian Journal of Public Health 41 (4):100–07. PMCID: PMC3481619.
   PubMed Web of Science ®Google Scholar
• Terell, R. R. 2010 Identifying and addressing individual conflicts of interest in research. The National association of college and university attorneys. http://www.higheredcompliance.org/resources/resources/xxv-10-06-9.doc ( accessed March 15 2018).
   Google Scholar
• Thompson, D. F. 1993. Understanding financial conflicts of interest. The New England Journal of Medicine 329 (8):573–76. doi:10.1056/NEJM199308193290812.
   PubMed Web of Science ®Google Scholar
• Tierney, W. M., E. M. Meslin, and K. Kroenke. 2016. Industry support of medical research: Important opportunity or treacherous pitfall? Journal of General Internal Medicine 31 (2):228–33. doi:10.1007/s11606-015-3495-z.
   PubMed Web of Science ®Google Scholar
• Wolf, L. E., J. F. Walden, and B. Lo. 2005. Human subjects issues and IRB review in practice-based research. Annals of Family Medicine 3 Suppl 1:S30–7. doi:10.1370/afm.302.
   PubMedGoogle Scholar
• Woolham, J. 2011. Research governance and ethics for adult social care research procedures, practices and challenges. NIHR School for Social Care Research, London. ISBN 978-0-85328-449–9.
   Google Scholar
• Yildirim, O., M. Gottwald, P. Schüler, and M. C. Michel. 2016. Opportunities and challenges for drug development: Public–private partnerships, adaptive designs and big data. Frontiers in Pharmacology 7:461. doi:10.3389/fphar.2016.00461.
   PubMed Web of Science ®Google Scholar